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Abstract 22
The ability to rapidly detect circulating small RNAs, in particular microRNAs (miRNAs), would 23 further increase their already established potential as biomarkers in a range of conditions. One rate-24 limiting factor is the time taken to perform quantitative real time PCR amplification. We therefore 25 evaluated the ability of a novel thermal cycler to perform this step in less than 10 minutes. 26
Quantitative PCR was performed on an xxpress® thermal cycler (BJS Biotechnologies, Perivale, 27 UK), which employs a resistive heating system and forced air cooling to achieve thermal ramp rates 28 of 10 °C/s, and a conventional peltier-controlled LightCycler 480 system (Roche, Basel, Switzerland) 29 ramping at 4.8 °C/s. The threshold cycle (Ct) for detection of 18S rDNA from a standard genomic 30 DNA sample was significantly more variable across the block (F-test, p=2.4x10 -25 ) for the xxpress 31 
Method summary 39
We describe a quantitative PCR platform which enables faster ramping between temperatures than 40 Introduction 47 PCR is ubiquitous throughout the life and medical sciences and a reduction in the time required to 48 complete a PCR reaction would therefore be of immense benefit. Whilst the choice of fast enzyme is 49 important for the optimization of fast PCR-based systems(1), (2), the speed at which the temperature 50 of the sample can be altered during thermal cycling is the primary rate-limiting factor (3). Using 51 prototype systems many investigators have demonstrated that rapid thermal cycling is possible (4), 52
(5), and under extreme conditions can be completed in less than one minute (6)! The predominant 53 format of existing thermal cyclers comprises a 96 or 384 well block, the temperature of which is 54 controlled by a peltier-based system limited to ramp rates of approximately 4 °C/s. Several 55 quantitative PCR systems which employ rapid thermal cycling are available commercially, but these 56 are based on glass capillaries (LightCycler, Roche) (7) or plastic tubes placed in a centrifuge (Rotor-57 gene, Qiagen, Crawley, UK). An alternative rapid plate-based approach, which can be more easily 58 integrated into existing workflows, has now been developed. The xxpress® thermal cycler (BJS 59 Biotechnologies) employs resistive heating and forced air cooling to enable ramp rates of up to 10 60 °C/s. 61
One of the main applications of PCR is for the quantitation of RNA targets. Following reverse 62 transcription into cDNA, amplification of targets is detected by incorporation of a double-stranded 63 DNA binding fluorescent dye (principally SYBR green) or use of a sequence-specific probe-based 64 system e.g. Taqman. This quantitative reverse transcription PCR (RT-qPCR) approach can be 65 modified to measure small RNAs, specifically miRNAs. Following the discovery that miRNAs exist 66 in a stable form within blood (8)(9)), their potential as biomarkers was soon realised. MiRNA 67 expression patterns characteristic of cancer, cardiovascular disease, diabetes, Alzheimer's and many 68 other conditions have now been reported (10)(11), (12, 12). Typically global miRNA profiles are 69 initially assessed in a discovery cohort using microarrays or deep sequencing and selected informative 70 miRNAs are subsequently measured in a larger population. The method of choice for measuring a 71 defined, diagnostic panel of miRNAs is RT-qPCR. 72
To perform RT-qPCR, RNA must be extracted from plasma or serum, reverse transcribed and target 73 miRNAs amplified in individual PCR reactions. This process takes several hours and is sufficient for 74 the current applications of circulating miRNA biomarkers for which results may be reported within 75 days or weeks. However, a more rapid assay would facilitate point of care diagnostics and expand 76 potential uses. For example, changes in miRNAs have been associated with cardiac disease (10)), and 77 the ability to measure them in plasma quickly might provide an earlier biomarker for diagnosis of 78 myocardial infarction and ensure more timely therapeutic intervention (13). We therefore assessed the 79 ability of the xxpress system to quantify miRNAs in plasma using high speed cycling in comparison 80 with an existing qPCR system (LightCycler480, Roche). 81
It was possible to amplify RNAs from plasma cDNA in less than 10 minutes using the xxpress 82 system, compared with ~40 minutes with the LightCycler. However, although the performance of 83 both systems was broadly comparable, variability across the plate and between replicate samples was 84 greater in the xxpress. 85 86
Materials and Methods 87

Oligonucleotide synthesis 88
All oligonucleotides (Integrated DNA Technologies, Leuven, Belgium) were reconstituted as 100 µM 89 stocks; DNA in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0), RNA in nuclease free water, and 90 stored at -80 °C. Sequences of the RNA miRNA mimic, Reverse transcription oligo, 18S and miRNA 91 primers are shown in Table 1 . 92 93 qPCR instruments 94
The xxpress system ( Figure 1 ) employs resistive heating and forced air cooling to facilitate rapid 95 changes in temperature. PCR reactions are performed within proprietary 'xxplates' which comprise a 96 metal base fused with plastic wells, meaning that the sample is only 10 µm from the heat source 97 ( Figure 1A ). To enable thermal uniformity across all the samples to within ±0.3 °C during holds at a 98 static temperature or within ±0.8 °C during fast ramping (10 °C/s), the xxpress uses an array of 99 infrared sensors to determine the temperature of the test samples and a control algorithm adjusts the 100 heating patterns at a rate of 100 times per second. The xxplates to be analysed using the xxpress 101 system were prepared as follows. Plates were sealed using xxpress compatible polarised sealing strips 102 heated at 170 o C for 1.5 s using the heat sealer provided ( Figure 1B ). They were then centrifuged at 103 1000 rpm for 1 minute in dedicated holders in the centrifuge provided before loading into the xxpress 104 cycling unit ( Figure 1B ). The LightCycler 480 system with a 384 well block installed has a thermal 105 uniformity of ±0.4 °C within 60 s of target attainment (72 °C). PCR plates (Roche) to be analysed 106 were prepared following the manufacturer's instructions (LightCycler 480 user manual). In brief, 107 plates were sealed using the manufacturer's sealing strips, ensuring all wells were securely covered, 108 followed by centrifugation at 1200 rpm for 2 minutes. Plates were then loaded into the LightCycler. 109
110
PCR conditions and data analysis 111
All PCR reactions were performed for 40 cycles with SYBR Fast qPCR Mastermix (final 112 concentration 1X, Kapa Biosystems, 1 µl DNA or cDNA template, 5 µM forward and reverse 113 primers) in a final volume of 5 µl. The cycling conditions used for amplification of 18S rDNA are 114 shown in Table 2 and employed the same ramp rate on both machines (4.8 °C/s). 18S rDNA 115 amplification used 1 µl of genomic DNA as template (2.5 ng/µl) either neat, or serially diluted in PCR 116 grade water. The same conditions were used for detection of miRNAs, but with a reduced 117 annealing/extension temperature of 55 °C and with ramp rates increased to 10 °C/s on the xxpress. 118
Raw fluorescence data were analysed by baseline normalisation and Ct values were called in 119 accordance with the data analysis software provided on each instrument (threshold set using the 120 second derivative maximum algorithm on the LightCycler and manually on the xxpress). 121
122
RNA templates 123
An RNA oligonucleotide with the sequence of miR-21 and a polyA tail (miRNA mimic) ( Table 1 ) 124 was reverse transcribed using 5 pmol of oligodT-RACE primer; the template was denatured at 50 °C 125 for 5 minutes, then cooled to 4 °C for addition of SuperScript III (Life Technologies, Paisley, UK) 126 
Results and Discussion 142
To assess consistency across the plate, a single mastermix for amplification of a 155 bp amplicon 143 from 18S rDNA was aliquoted into 48 wells distributed evenly across each type of plate (Suppl. 144 Figure. 1). Amplification was performed using the same cycling conditions on both systems (Table 2) . 145
The mean Ct values were very similar from the xxpress (20.01±0.47SD) and the LightCycler 146 (19.87±0.04SD), although the LightCycler was significantly lower (t-test, p = 0.035). However the 147 xxpress exhibited significantly greater variability than the LightCycler, which generated extremely 148
consistent Ct values (F-test, p=2.4x10 -25 ) (Figure 2 ). Although the performance of the xxpress was 149 less robust, it could still be used in situations requiring rapid detection of large variations in 150 expression between samples (with the inclusion of appropriate replicates). The spread in Ct values on 151 the xxpress was in part linked to the position of the sample on the xxplate, with adjacent wells tending 152 to vary from the mean Ct value in the same direction. The greater variation observed with the xxpress 153 may not be due to poorer temperature control across the plate, but could be related to the optical 154 system, which is amenable to improvement in subsequent versions. To compare the sensitivity of the 155 two platforms, highly abundant 18S rDNA was amplified from a dilution series of genomic DNA. The 156
mean Ct values at each template concentration were not significantly different between platforms (t-157 test, p>0.05). In both cases the Ct values were highly correlated with template concentration 158 (LightCycler, R² = 0.9547; xxpress, R² = 0.9878), although again there was a significantly greater 159 variation in Ct values for replicates in the xxpress at several concentrations ( Figure 3A ). 160
The method described by Shi and Chiang (14)), was then used to detect miRNAs. Total RNA, 161
including miRNAs, is polyadenylated and then reverse-transcribed with a poly(T) adapter into 162 cDNAs. These are subsequently amplified using a miRNA-specific forward primer and a sequence 163 complementary to the poly(T) adapter as the reverse primer. Initially we tested the ability of each 164 platform to detect a miRNA mimic synthesised with a polyA tail already incorporated (thereby 165 removing any variability associated with the polyadenylation reaction). The limit of detection, as 166 estimated from the linear portion of the standard curve, was approximately 1x10 6 RNA template 167 molecules for both systems ( Figure 3B ). Given the high concentrations of specific template miRNA 168 used in this assay, a better signal may be obtained using cell-derived RNA as template (15)). 169
Our ultimate aim is the rapid detection of miRNAs from blood as biomarkers of cancer and other 170 diseases. As a step towards this we measured the expression of several miRNAs in RNA extracted 171 from three human plasma samples; miR-21, an 'oncomir' which plays a role in many types of cancer 172 (16), (17),(18)and heart disease (19)) and has been reported to be elevated in blood from cancer 173 patients (20), (21), miR-22, which has is also differentially expressed in various types of cancer (22)), 174 miR-126, which is involved in regulation of angiogenesis (23)) and miR-486, which is down-175 regulated in lung cancer and proposed as a biomarker for detection of lung cancer in plasma samples 176 ((24), (25)). The results of quantification of these four miRNAs following forty cycles of PCR, 177 completed in less than 10 minutes with the xxpress compared to 40 minutes using the LightCycler, are 178 presented in Figure 4 . The relative abundances of the miRNAs detected by both systems were similar, 179 albeit with greater variation between technical replicates on the xxpress. MiR-21 was the most 180 abundant (lowest Ct) and miR-22 the least abundant (highest Ct) miRNA for all samples on both 181 platforms. Significant differences between platforms in Ct values were observed for many miRNAs 182 amplified from the same sample (e.g. miR-126 in plasma sample 2, p <0.001). This is likely due to the 183 combined effects of differences in the sample temperatures achieved during cycling, the detection 184 systems and performance of the individual assays under different conditions. Another class of small 185 RNA, a Y RNA fragment (hY4-3p) recently shown to be present in plasma (26), (27, 28) was detected 186 consistently by both platforms (∆Ct between the two platforms across three plasma samples was 2.3 187 ±0.3SD) and could potentially provide a stable reference gene. 188
Faster PCR can be achieved by reducing hold times and although this can reduce sensitivity and 189 increase variability (29)) , enzymes are now available from a range of manufacturers which perform 190 well in fast PCR. All data reported were generated with SYBR fast qPCR Mastermix (Kapa 191 Biosystems) but 18S rDNA failed to amplify using Quantitect (Qiagen) on the xxpress, so users 192 should be aware that rigorous optimisation of different mastermixes is required for fast PCR. To 193 facilitate development of rapid assays incorporating fast PCR pre-processing steps must be minimised 194 and there is therefore a growing need to develop enzymes resistant to contaminants and inhibitors 195 present in a range of biological sample materials, such as soil, water and blood (30)). 196
Although many prototype rapid PCR systems have been reported with extremely fast ramp rates and 197 miniaturisation (5), (6), (31)) very few proceed to commercial release. Therefore the xxpress rapid 198 thermal cycler, particularly given its standard block-based design, offers a unique opportunity for the 199 wider molecular research community to adopt fast PCR. The potential applications of fast PCR in 200 situations which require a rapid diagnosis (e.g. involvement of cardiac disease in dyspnoea (32)) or 201 chest pain) make this an exciting and rapidly expanding area of PCR development. If protocols can be 202 developed to enable reverse transcription and PCR directly from patient samples (30)), this platform 203 has the potential to make point-of care diagnostics based upon circulating microRNAs a reality. 
